Tickerplace logo

Tickerplace

Avenue Therapeutics, Inc. logo

ATXIAvenue Therapeutics, Inc.

ATXI Stock Price, Valuation & Chart | Avenue Therapeutics, Inc.

Compare
$0.570+0.05 (+9.62%)

At close · 02 Sept 2026, 07:50 pm

Sector: HealthcareIndustry: BiotechnologyATXI intrinsic valueATXI calculated fair value vs price
OverviewFinancialsDividendsRatios

ATXI Historical price chart

ATXI Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.88M
PE Ratio-0.67
EPS-0.85
Trading Volume2.75K
Today's High/Low0.57/0.49
Dividend Yield0.00
52 Week High/Low0.97/0.15
Shares Outstanding3.29M
ATXI Financial Statement
ATXI Analyst ratings
ATXI Analysis & performance metrics

ATXI Company profile

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its…

ATXI Management team

Management
Lindsay Allan RosenwaldCTO
Executive Director
David JinCFO
Interim Chief Financial Officer, Chief Operating Officer & Corporate Secretary
Alexandra MacLean M.D.CEO
Chief Executive Officer & Director
Scott A. Reines M.D., Ph.D.
Interim Chief Medical Officer
Total 4 executives

ATXI Frequently asked questions

What is Avenue Therapeutics, Inc. (ATXI) Stock Price?

Current stock price of Avenue Therapeutics, Inc. (ATXI) stock is $0.570. The stock price is +9.62% higher in the session. The intraday range can be seen from this page. Volume of Avenue Therapeutics, Inc. (ATXI) stock is 2.75K.

Last updated at 02 Sept 2026, 07:50 pm.

Why is the Avenue Therapeutics, Inc. (ATXI) stock price going up or down today?

The stock price of Avenue Therapeutics, Inc. (ATXI) can change with earnings, company news, and overall market sentiment. Avenue Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Avenue Therapeutics, Inc. stock expensive at its current price?

Whether Avenue Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ATXI on this page is -0.67. EPS on this page is -0.85. Compare those figures with peers and growth expectations before deciding if the current Avenue Therapeutics, Inc. price is justified.

How has the stock price of Avenue Therapeutics, Inc. (ATXI) performed historically?

Historical performance for Avenue Therapeutics, Inc. (ATXI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ATXI reacted to past earnings and market events.

Should I buy Avenue Therapeutics, Inc. (ATXI) stock, at this price?

Buying Avenue Therapeutics, Inc. (ATXI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.